Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Symptomatic uncomplicated diverticular disease management: an innovative food-grade formulation of and extracts.

< BACK TO ARCHIVE


2020


Drugs Context


http://www.ncbi.nlm.nih.gov/pubmed/33408751?dopt=Abstract


9

Symptomatic uncomplicated diverticular disease management: an innovative food-grade formulation of and extracts.

Authors

Symptomatic uncomplicated diverticular disease management: an innovative food-grade formulation of and extracts.
Giacosa A, Riva A, Petrangolini G, Allegrini P, Fazia T, Bernardinelli L, Gasparri C, Faliva M A, Peroni G, Perna S, Rondanelli M
Drugs Context. 2020; 9.
PMID: 33408751.

Abstract

The treatment of symptomatic uncomplicated colonic diverticular disease (SUDD) is still under debate, and new data show a pathogenic role of dysbiosis and low-grade inflammation in intestinal mucosa. Recent research has highlighted the anti-inflammatory effects of botanical extracts such as L. and Roxb. ex Colebr. The aim of this work is to investigate the potential role of a new delivery formulation of the association of curcumin and boswellia phytosome extracts (CBP) in SUDD.
Read This Paper